Guardant Health (GH) Shares Outstanding (Weighted Average) (2017 - 2025)
Guardant Health (GH) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $125.4 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 2.14% to $125.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.4 million through Dec 2025, up 2.14% year-over-year, with the annual reading at $125.4 million for FY2025, 2.14% up from the prior year.
- Shares Outstanding (Weighted Average) hit $125.4 million in Q4 2025 for Guardant Health, roughly flat from $124.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $125.4 million in Q4 2025 to a low of $101.0 million in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $112.1 million across 5 years, with a median of $110.4 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.64% in 2022 and later rose 18.55% in 2024.
- Year by year, Shares Outstanding (Weighted Average) stood at $101.3 million in 2021, then increased by 0.85% to $102.2 million in 2022, then grew by 9.6% to $112.0 million in 2023, then increased by 9.61% to $122.7 million in 2024, then grew by 2.14% to $125.4 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for GH at $125.4 million in Q4 2025, $124.8 million in Q3 2025, and $124.0 million in Q2 2025.